Claude, Eloïse
de Lhoneux, Guillaume
Pierreux, Christophe E.
Marbaix, Etienne
de Ville de Goyet, Maëlle
Boulanger, Cécile
Van Damme, An
Brichard, Bénédicte
Decottignies, Anabelle http://orcid.org/0000-0001-7893-2527
Funding for this research was provided by:
fonds de la recherche scientifique - fnrs (7.6519.20)
fondation contre le cancer (2018-072-project # FAF-F/208/1208)
king baudouin foundation (2016-J1151710-206515)
Article History
Received: 5 July 2021
Accepted: 14 September 2021
First Online: 20 October 2021
Declarations
:
: Xenograft experiments were performed in accordance with national and institutional guidelines for animal care, under permit numbers 2016/UCL/MD/009 and 2020/UCL/MD/012. The tumor volume did not exceed 1500 mm<sup>3</sup> for xenografts in mice. Animals were sacrificed by cervical dislocation when any kind of animal suffering was detected or if no sign of tumor formation was detected after 5 months. Analysis of human tumor samples has been approved by the local ethics committee (Comité d’Ethique Hospitalo-Facultaire) under reference 2017/27JUI/335 (Belgian registry: B403201732874). All participating patients provided informed consent.Signed informed consent forms were obtained from parents/tutors of all paediatric patients included in this study.
: Parents/tutors of all paediatric patients agreed that tumor analysis results may be published anonymously.
: The authors declare no competing interest.